MagMen-II Phase 3 Sentinel Node Melanoma Trial
Summary
NIH has registered the MagMen-II clinical trial (NCT07552597) on ClinicalTrials.gov as a Phase 3 study evaluating sentinel node biopsy procedures in melanoma patients. The trial is listed in the registry with standard enrollment information. Clinical trial registrations on ClinicalTrials.gov are informational entries that do not create compliance obligations for third parties.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 21 changes logged to date.
What changed
NIH has added the MagMen-II clinical trial to ClinicalTrials.gov as a new Phase 3 registry entry. The trial, identified as NCT07552597, studies sentinel node biopsy in melanoma treatment. Clinical investigators and healthcare providers involved in melanoma research should note this trial for awareness purposes. The registry entry does not impose reporting requirements or compliance obligations on institutions not participating in the study.
For clinical operations teams, this registration serves as an informational resource for identifying ongoing Phase 3 melanoma trials. Institutions considering participation in melanoma clinical research may wish to review inclusion criteria and recruitment status directly on ClinicalTrials.gov.
Archived snapshot
Apr 28, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.